Forecast

Buy	0
Hold	1
Sell	0

News Go to news feed

Ontex reports sales decline in 2025 and targets 10% EBITDA growth for 2026

Ontex recorded a sales decline in 2025 to €1,762m and an adjusted EBITDA of €176m (margin 10.0% vs. 12.0% in 2024), driven by weak baby-care demand, higher raw material costs and operational disruptions. The company posted an overall loss of €174m, which included a €190m loss from discontinued operations, and generated a negative free cash flow of -€25m. Net debt fell to €577m, but the leverage ratio rose to 3.3x. For 2026 Ontex expects broadly stable sales, a 10% increase in adjusted EBITDA, a return to positive free cash flow and a reduction of leverage to around 3.0 or below; measures include cost transformation, efficiency improvements and a strategic review. » More on de.investing.com
Ontex accelerates CEO change and launches comprehensive strategy review

Ontex has brought forward the leadership change: Laurent Nielly assumes the role of CEO with immediate effect, while Gustavo Paz will remain until the end of January to facilitate the handover. The company announced a full strategic review of its portfolio, operational setup and distribution channels and has established a strategy committee of the board. The measures are aimed at higher cash generation and improved returns; the announcement sent the share price markedly higher. » More on de.investing.com
S&P cuts outlook for Ontex to stable after second profit warning

S&P Global Ratings has downgraded the outlook for Ontex from “positive” to “stable”; the B+ rating remains unchanged. The move follows a second profit warning for 2025 with a lowered sales forecast (core markets: −4 to −6 %) and adjusted EBITDA of €175–180m. S&P expects a reported sales decline of around 14% in 2025, an EBITDA margin of about 7.5% and no positive free operating cash flow. For 2026 S&P anticipates a moderate recovery (sales ~€1.79–1.80bn, adjusted EBITDA margin towards 10% and FOCF around €30m); Ontex also plans a €200m cost-efficiency program for 2026–2028. » More on de.investing.com

Historical dividends Dividends

All dividend metrics All metrics

In 2019, Ontex Group has already paid 0,41€ in dividends. The last payout was in June 2019.

Financials

In the last quarter, Ontex Group had revenue of 854,80M€ and net profit of −143,00M€

(EUR)	Jun 2026	YoY
Revenue	+854,80M	-
Gross profit	+232,00M	-
Net profit	−143,00M	-
EBITDA	+78,20M	-

Fundamentals

Metric	Value
Market capitalization	+209,70M€
Number of shares	79,73M
52-week high/low	+6,72€ - +2,13€
Dividends	No
Beta	0,71
P/E ratio	−1,04
PEG ratio	+0,01
P/B ratio	+0,26
P/S ratio	+0,12

Company profile

Die Ontex Group NV bietet Körperpflegelösungen für die Baby-, Damen- und Erwachsenenpflege in Westeuropa, Osteuropa, Nord- und Südamerika, Mexiko, dem Vereinigten Königreich, Italien, Frankreich und international an. Das Unternehmen bietet Produkte für die Babypflege wie Windeln und Höschen sowie Feuchttücher unter den Marken Baby Pants, Bbtips, Bio Baby, Chicolastics, Canbebe, Cremer Disney, Helen Harper, Kiddies, Little Big Change, Moltex, Pom Pom, Sapeka und Mônica sowie Produkte für die Damenhygiene wie Damenbinden, Slipeinlagen und Tampons unter den Markennamen Fiore, Mia, NAT, Sincere und Silhouette. Das Unternehmen bietet auch Inkontinenzprodukte für Erwachsene an, darunter Höschen und Windeln für Erwachsene, Inkontinenzhandtücher und Bettschutzprodukte unter den Markennamen A Lovely Day, Adultmax Maturidade, Affective, Bigfral, iD, Canped, Affective, Lille Healthcare, Kylie, Serenity, Orizon und Moviment; außerdem produziert und verkauft es Gesichtsmasken. Das Unternehmen vertreibt seine Produkte an Verbraucher, Einzelhändler sowie institutionelle und private Gesundheitsdienstleister und bietet Produkte unter Einzelhandelsmarken an. Die Ontex Group NV wurde 1979 gegründet und hat ihren Hauptsitz in Aalst, Belgien.

Name	Ontex Group
CEO	Laurent Nielly
Headquarters	Aalst, vlg Belgium
Website	ontex.com
Sector	Consumer Staples
Industry	Personal Care Products
IPO	06/25/2014
Employees	5.000